ReviewJournal of clinical hypertension (Greenwich, Conn.)2021

Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe.

Donna S-H Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.